Doniphan County Legal THCa Rick Simpson Oil: OilWell Cannabis Ships Houston’s 16,590mg 7-Cannabinoid RSO Sublingual with 553mg/mL Potency, Patient-Controlled 1,500mg THCa-to-THC Conversion for Up to 1,405mg Activated THC, ABC13-Featured & Texas DSHS Licensed with COA-Backed Open-Source Formulas, No Medical Card Required — Bentley’s Paralyzed Dog Miracle Legacy Since 2019

Rick Simpson Oil in Doniphan County: The Complete Guide by OilWell Cannabis

If you live in Doniphan County and you’re searching for real answers about Rick Simpson Oil—what it is, where it comes from, whether it actually works, and how to get it legally—you’re in the right place. We’re OilWell Cannabis, a Houston-based company that’s spent the last decade building what we believe is the most honest, research-backed, and accessible RSO formula available anywhere. We wrote this guide because people in rural Kansas communities like Doniphan County deserve the same depth of information that patients in Houston or Los Angeles get, without the hype, without the legal ambiguity, and without having to drive three hours to a dispensary that may not even have what you need.

We know Doniphan County. We know Troy, Wathena, Elwood, Highland. We know you’re dealing with chronic pain that makes it hard to work the fields or run your small business. We know some of you are cancer patients at the Northeast Kansas Cancer Center in St. Joseph, wondering if there’s anything beyond the nausea and exhaustion of chemo. We know veterans in Doniphan County struggling with PTSD and sleep, trying to avoid another pill that leaves you groggy and disconnected. We’ve built this product and written this guide for you—not as a sales pitch, but as the educational foundation we wish we’d had when we started.

Who Is Rick Simpson, and Why Does His Story Matter in Doniphan County?

Rick Simpson was a power engineer from Nova Scotia—not a doctor, not a scientist, not a medical professional. He was a blue-collar tradesman, the kind of guy you’d meet at the grain elevator in Highland or the co-op in Wathena. In 1997, he fell from scaffolding at a hospital job, suffered a severe head injury, and developed persistent tinnitus, dizziness, and post-concussion symptoms that his doctors couldn’t fix. The medications they prescribed either didn’t help or made things worse. When he asked his physician about cannabis, the doctor refused to consider it. Sound familiar? That’s a story we hear from patients in Doniphan County all the time—frustration with a medical system that sometimes dismisses alternatives before truly listening.

Simpson’s interest in concentrated cannabis oil deepened after he learned about a 1974 NIH-funded study at the Medical College of Virginia that reported THC could slow or shrink tumors in mice. That study was intended to prove harm, not benefit, and its findings were never replicated in controlled human cancer trials—but it planted a seed. Then came 2003. Simpson discovered three bumps on his arm that his doctor diagnosed as basal cell carcinoma. Instead of pursuing conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. No biopsy, no clinical follow-up, no peer-reviewed documentation. Just his personal testimony. That moment—however medically unverified—became the origin story of Rick Simpson Oil and launched a global movement.

Important context: Simpson’s account is historical, not medical evidence. It cannot be evaluated as clinical proof. But it is historically significant as the catalyst that made concentrated cannabis oil a household name in every corner of the world—including Doniphan County.

The Traditional RSO Protocol: What Simpson Actually Recommended

Simpson’s core protocol was specific: 60 grams of concentrated cannabis oil over approximately 90 days, delivered through a precise titration schedule.

• Week 1: Half a grain of rice-sized dose (10-15 mg) three times daily.
• Weeks 2-5: Double the dose every four days, building to 1 gram per day.
• Weeks 5-12: Maintain 1 gram per day, divided into three doses, until all 60 grams are consumed.

He recommended oral (sublingual) administration as primary, topical application for skin lesions, and acknowledged inhalation only for immediate symptom relief—not as the main treatment. He believed patients would develop tolerance to psychoactive effects within 3-4 weeks and urged nighttime dosing initially to sleep through the high.

He also gave the oil away for free. In Maccan, Nova Scotia, he produced large quantities and distributed them to cancer patients and others with chronic pain, diabetes, glaucoma, arthritis, depression, insomnia—charging nothing. His 2005 documentary Run From The Cure spread his story globally, becoming foundational cannabis education for millions.

But here’s what most people in Doniphan County never hear: Simpson’s protocol was never validated in a controlled trial. The doses he recommended—600-900 mg of delta-9 THC per day at peak—far exceed anything studied in clinical settings. The FDA-approved THC drug dronabinol is typically dosed at 2.5-20 mg per day. At 600-900 mg daily, patients face real risks: severe intoxication, anxiety, panic, tachycardia, hypotension, and cannabis use disorder. For cancer patients already medically complex, using unregulated, unstandardized oil as a primary treatment—potentially in place of proven therapies—carries genuine harm potential. Delayed or foregone treatment is a documented concern in alternative medicine.

The Traditional RSO Product: What It Actually Was

Understanding what Simpson made is critical for Doniphan County residents comparing what’s sold locally.

Source material: Single high-THC indica strain, no standardization. Every batch varied.

Extraction solvent: Naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol—neither food-grade. Incomplete solvent purging leaves residues that are difficult to verify without lab testing.

Process: Plant material soaked in solvent, filtered, evaporated in a rice cooker at high heat, resulting in a thick, tar-like, nearly black oil.

Cannabinoid profile: 60-90% delta-9 THC, fully decarboxylated. Minor cannabinoids present at natural, uncontrolled ratios. No lab verification.

Terpene content: Essentially zero. High heat destroyed them.

Standardization: None. Every batch differed.

Residual solvent risk: Naphtha may contain benzene, toluene, xylene—toxic compounds. This is one of the biggest safety concerns with traditional production.

In short: traditional RSO was a crude, variable, untested extract. The term “RSO” today is used loosely—many products bearing the name bear little resemblance to Simpson’s original. That’s not necessarily bad, but Doniphan County consumers need to understand the difference.

Simpson’s Claims vs. The Evidence: What the Science Actually Says

Simpson claimed RSO could cure cancer and dozens of other diseases. Evaluating those claims requires honesty—something many RSO sellers avoid.

What Simpson was not: He had no medical training, conducted no clinical trials, published no peer-reviewed research. His evidence was personal experience and testimonials.

What preclinical research shows: In vitro and animal studies demonstrate THC and CBD can induce apoptosis (programmed cell death), inhibit tumor proliferation, and reduce angiogenesis in certain cancer cell lines. Animal models show some tumor-growth inhibition. This is scientifically interesting but not proof of human cancer cures.

What preclinical research does not show: These findings have not translated into proven human cancer cures. The gap between animal results and human outcomes is vast. No human clinical trial has demonstrated RSO cures cancer.

Institutional positions:

• National Cancer Institute acknowledges anticancer research but does not endorse cannabis as a cancer treatment.
• FDA has not approved any cannabis plant product for cancer. Only purified CBD (Epidiolex) and synthetic THC analogues (dronabinol, nabilone) are approved for specific non-cancer indications.
• Health Canada has never approved RSO for cancer.
• NCCIH identifies strongest evidence for rare epilepsies, chemo nausea, and HIV/AIDS appetite—not cancer cure.

What Simpson got right: He drew attention to cannabinoids as serious biomedical research when the world ignored them. He helped create conditions for today’s legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract. These contributions are real and historically significant.

What he overstated: Cure claims exceeded the evidence. Encouraging patients to use RSO instead of proven cancer therapies carries genuine harm potential. Delayed treatment is a documented risk.

Modern RSO has evolved substantially—not because Simpson was wrong, but because we now have tools he didn’t: legal frameworks, lab testing, standardized formulations, and peer-reviewed research.

OilWell’s RSO Philosophy: Accessibility, Control, Transparency, Evidence

We at OilWell built our RSO formula to honor Simpson’s vision while solving the problems his approach created. Four principles guide everything:

1. Accessibility over gatekeeping. No medical card required. Anyone 21+ can purchase. We ship nationwide and internationally. Simpson believed medicine should be accessible; we built a legal distribution model that makes that real for Doniphan County residents who can’t drive to a Missouri dispensary.

2. Patient-controlled potency. We preserve THCa in its acidic, non-psychoactive form. You decide: use it raw for daytime anti-inflammatory benefits without impairment, or decarboxylate it at home into 1,405 mg of total THC for full psychoactive potency. Simpson believed patients should control their medicine; we engineered that control into the product’s chemistry.

3. Open-source formulas. We publish every milligram amount publicly. If you can’t afford our product, you can source the ingredients and make your own. Simpson gave his oil away free and taught people to make it; we sell a professional, lab-tested product and publish the recipe.

4. Evidence-informed, not evidence-overstating. This entire guide is anchored to peer-reviewed research. Simpson operated without access to clinical data; we have that access and use it to distinguish what’s proven, what’s emerging, and what’s overstated.

The Origin of OilWell: A Story That Started With a Dog Named Bentley

OilWell wasn’t born in a boardroom. It was born in a living room in Houston when Colin Valencia’s dog Bentley was paralyzed and facing euthanasia. The vets said pain meds would destroy Bentley’s organs. The choice was prolonged suffering or immediate death. Colin refused to accept that.

A rescue worker named Jessica asked a question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?” Colin had cannabis experience, but it was recreational—getting high. He’d never explored medicine. Jessica’s question exposed a blind spot that became a mission.

Colin created CBD golden paste for Bentley. The result wasn’t placebo—dogs don’t respond to placebo. Bentley got up, walked across the room, and brought Colin his ball to play. The paralyzed dog that was supposed to die lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition Bentley faced: neurodegeneration, dementia, glaucoma, crippling arthritis. Single cannabinoids weren’t enough. Bentley’s evolving conditions required multi-cannabinoid synergy and pharmaceutical precision—his life depended on it.

That decade of formulation development on a patient Colin loved more than anything is why OilWell’s RSO has seven cannabinoids instead of one. It wasn’t a marketing decision. It was born from necessity.

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he quit Xanax cold turkey—a notoriously dangerous feat—he used the same cannabinoid knowledge that saved Bentley. The Peace Gummies formula was created during midnight experiments while fighting benzo withdrawal. Colin personally uses the vape form for insomnia and severe PTSD. This isn’t theoretical. He lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills don’t.

Growing up in McAllen, Texas, on the border with Reynosa, Colin faced poverty, violence, and cartel activity. By sixteen, he had to leave home. He could have taken darker paths, but chose cannabis as a safer alternative. He learned the plant intimately while operating in the shadows, then transitioned to legal business. He became a software engineer, did custom development for Baylor College of Medicine, and combined deep plant knowledge with medical-grade technical precision. That combination defines OilWell.

Today, OilWell operates from Montrose in Houston at 810 Richmond Avenue. We’ve been in business since 2019, generate about $1M annual revenue, maintain a near-5.0 Google rating, and hold a Texas DSHS license. All formulations, artwork, and packaging are created in-house in Houston using only our own recipes and ideas. We’re not here to follow trends. We’re here to set them.

Seven times between 2019 and 2023, ABC13 Houston—America’s fourth-largest city’s number-one news source—featured Colin as the primary cannabis industry expert. Five different reporters sought him out for stories spanning law, medicine, business, community health, and politics. That recognition can’t be purchased. It’s earned through consistency, expertise, and character.

Farm Bill Compliance and the THCa Legal Framework: Why This Matters in Doniphan County

The 2018 Farm Bill legalized hemp-derived products containing less than 0.3% delta-9 THC by dry weight. This is the foundation of legal access for Doniphan County residents.

Our RSO Sublingual Oil contains only 90 mg of delta-9 THC in the entire 30 mL bottle—3 mg per mL. Well under the legal threshold. All cannabinoids are hemp-derived and Farm Bill compliant.

THCa is the game-changer. It’s the acidic, non-psychoactive precursor to THC. It’s not delta-9 THC, which means it’s legal at the point of sale. You can legally purchase, possess, and transport our product in Doniphan County. The conversion happens at your discretion:

Home decarboxylation: Heat the oil at 260°F for 45-60 minutes in an oven-safe glass container. This converts 1,500 mg THCa into approximately 1,315 mg delta-9 THC. Combined with the existing 90 mg, you get ~1,405 mg total delta-9 THC—plus 6,000 mg delta-8 THC. That’s psychoactive potency comparable to traditional illegal RSO, entirely legal because you control the activation.

Three usage options:

1. Raw (no heat): All 1,500 mg stays as THCa—completely non-psychoactive, perfect for daytime use while working, driving, or parenting. Provides anti-inflammatory benefits via COX-2 inhibition and neuroprotective potential via PPARγ agonism.
2. Fully activated (home decarb): Convert the THCa for full psychoactive potency. Ideal for nighttime use, severe breakthrough pain, or when you want the traditional RSO experience.
3. Vape (auto-decarb): Our vape cartridge instantly converts THCa at 400-450°F, delivering freshly activated cannabinoids with each puff—fastest onset available.

This patient-controlled potency reflects Rick Simpson’s principle that patients should control their medicine, implemented through actual chemistry.

Important legal notice: THCa converts to delta-9 THC when heated. Customers are responsible for understanding and complying with local laws. We ship with full documentation, COAs, and receipts. International customers accept all customs and legal risk.

Open-Source Formulas: Why We Publish Everything

We publish our complete RSO formulas publicly. If you can’t afford the product, you can source ingredients and make your own. This echoes Simpson’s free-distribution ethos but adapts it for modern access.

The CBD golden paste recipe that saved Bentley is also published free on our website. That’s not marketing—it’s foundational behavior. We gave away the formula that saved a dog before we gave away the formula for people.

The RSO Sublingual Oil Formula (Open-Source)

• Live terpenes: 5%
• Format: 30 mL bottle
• Active cannabinoids per mL: 553 mg
• Organic MCT oil base
• Graduated dropper (0.1 mL increments)
• Onset: 15-45 minutes (sublingual)
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Approximately 40-60 doses per bottle

The RSO Vape Cartridge Formula (Open-Source)

• Live terpenes: 5%
• Format: 1 gram cartridge
• 510-thread universal battery compatibility
• Onset: 1-2 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Auto-decarboxylation at vaping temperature

Terpene Profile (Both Products)

• Limonene (citrus-bright)
• Myrcene
• Caryophyllene (β-caryophyllene – pepper/spice)
• Pinene (forest-fresh)
• Linalool (floral, lavender)
• Humulene (earthy, woody)
• Terpinolene (piney, fruity, sparkling)

This seven-terpene profile complements the cannabinoid formula: limonene for mood, myrcene for relaxation, caryophyllene for CB2 activation, pinene for clarity, linalool for calm, humulene for inflammation, terpinolene for complexity.

Solvent-Free Production: Safety You Can Verify

We don’t use naphtha, isopropyl alcohol, butane, or any extraction solvents. Our product is a formulated blend of individual cannabinoid distillates and isolates combined in a controlled environment.

We use organic MCT oil as the carrier—a food-grade lipid that facilitates absorption and provides neutral taste, unlike the tar-like consistency and solvent odor of traditional RSO.

Third-party lab testing covers:

• Cannabinoid potency (verified to ±2% accuracy)
• Terpene profile
• Pesticides (400+ compound screening)
• Heavy metals (arsenic, cadmium, lead, mercury)
• Residual solvents (FDA Class 3 limits)
• Microbial contaminants (E. coli, Salmonella, Aspergillus)

Certificates of Analysis (COAs) are available on request and via our website. This level of testing is impossible with traditional RSO production and represents one of the most important safety improvements in modern cannabis.

When to Use Each Format: A Practical Guide for Doniphan County

Competitive Comparison: Why OilWell RSO Stands Apart

OilWell vs. Texas Medical Cannabis (TCUP)

• TCUP requires a medical card with qualifying conditions (cancer, PTSD, epilepsy, terminal illness). Doniphan County residents would need to travel to a Texas dispensary.
• OilWell: Age 21+, no card required, ships directly to Doniphan County.
• TCUP RSO is THC-only (~420 mg per 0.5 g syringe). OilWell: seven cannabinoids, 16,590 mg total.
• TCUP: always psychoactive. OilWell: patient-controlled potency.

OilWell vs. Hemp CBD RSO (e.g., Lazarus Naturals)

• Lazarus: 1,000 mg total cannabinoids in 10 mL bottle. OilWell: 16,590 mg in 30 mL (16x more actives).
• Lazarus: minimal CBG, CBN, CBC. OilWell: 3,000 mg CBG, 750 mg CBN, 750 mg CBC.
• Lazarus: non-psychoactive only. OilWell: optional psychoactive activation.

OilWell vs. Traditional Illegal RSO

• Traditional: crude extraction, toxic solvents, no testing, unknown potency, no terpenes.
• OilWell: solvent-free, third-party tested, standardized at 553 mg/mL, 5% live terpenes, seven defined cannabinoids.

Condition-Specific Usage Context for Doniphan County Residents

Important Disclaimer: These contexts are informed by research cited in our GENERAL KNOWLEDGE section. They are not medical prescriptions, not FDA-approved, and not substitutes for professional care. Consult your healthcare provider—whether that’s your primary care physician in Troy, a specialist in St. Joseph, or a pain clinic in Kansas City—before using cannabinoid products.

Chemotherapy-Related Nausea and Appetite Support

• Pre-chemo: 0.5-1.0 mL sublingual ~1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support during treatment: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN)

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

• Daytime: 0.3-0.5 mL raw sublingual—anti-inflammatory without impairment
• Nighttime: 0.5-1.0 mL decarbed sublingual—pain relief + CBN sleep support
• Breakthrough pain: Vape as needed

Sleep Support

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL: 50 mg CBN (dosage level from 2024 sleep literature)
• At 1.0 mL: 25 mg CBN (above threshold for reduced sleep disturbance)

Anxiety and Stress

• Daytime functional relief: 0.3 mL raw sublingual (CBD + CBG without impairment)
• Nighttime: 1.0 mL sublingual (full profile + CBN)

General Titration Principle: Start low, go slow. Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary by weight, metabolism, tolerance, and concurrent medications.

Delivery and Global Accessibility: How Doniphan County Residents Get OilWell RSO

We are the only company offering same-day RSO delivery in Houston, but for Doniphan County, we provide:

Nationwide Shipping

• USPS Priority Mail (2-3 business days)
• FedEx/UPS Ground (3-5 business days)
• Discreet packaging—no cannabis branding visible
• Tracking provided
• Temperature-stable packaging for Kansas summers
• Signature-required option available

International Shipping
We ship to multiple countries across six continents. The THCa legal framework makes this possible: less than 0.3% delta-9 THC at sale means it meets hemp definitions in many jurisdictions. All packages include full documentation, COAs, and customs receipts. Customers accept all legal and customs responsibility.

For Doniphan County Specifically:

• No need to drive to Missouri dispensaries
• No medical card required (unlike Kansas medical program)
• Legal under federal Farm Bill
• Ships directly to your address in Troy, Wathena, Elwood, Highland, or anywhere in the county
• Discrete delivery respects rural community privacy

Our PANDEM1C SEO technology—a proprietary system with 14 million geopolitical locations and 300+ AI models—drives organic search visibility across six continents, making our products discoverable to international patients searching in their own language. But for you in Doniphan County, the key is simple: we can legally ship to your door.

The Science Behind Every Cannabinoid in Our Formula

CBD (4,500 mg)

• Evidence: Strongest human data in our formula. Best supported for rare epilepsies (FDA-approved as Epidiolex).
• Anxiety: 2024 meta-analysis of 316 participants showed significant anxiolytic signal, but authors stress limited clinical samples need more trials [3].
• Pain: 2024 systematic review found promising but heterogeneous evidence; trial quality limits broad claims [4].
• Sleep: 2023 review found literature methodologically weak, needing better-designed trials [5].
• Safety: 2023 meta-analysis found real signal for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy [6]. Also: decreased alertness, GI effects, appetite changes, mood effects, drug interactions [1].

CBG (3,000 mg)

• Evidence: Mostly review and preclinical; human evidence sparse [7][8].
• Pharmacology: Biosynthetic precursor to major cannabinoids. Interacts with cannabinoid receptors, alpha-2 adrenoceptors, 5-HT1A signaling—mechanistically interesting but not clinically established [7].
• Research areas: Possible relevance to neurologic disorders, inflammatory bowel disease, antibacterial activity—but primarily pharmacology-led hypotheses [7][8].
• Caution: Commercially sold while evidence base remains thin; claims often outrun science [7].
• Bottom line: Promising minor cannabinoid with limited clinical validation [7][8].

Delta-8 THC (6,000 mg)

• Evidence: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 THC [9]-[11].
• Pharmacology: 2022 review concluded delta-8 and delta-9 have broadly similar PK/PD behavior. Delta-8 is partial CB1 agonist, less potent than delta-9, likely due to weaker CB1 affinity [9].
• Public health: 2023 scoping review found evidence base dominated by animal studies, product chemistry, use reports, and safety concerns—not strong human trials [10].
• Manufacturing: Commercial interest tied to greater stability and easier synthesis relative to naturally scarce plant levels; product byproduct and lab-testing concerns are real [11].
• Bottom line: Psychoactive THC analogue with incomplete human safety/efficacy characterization [9]-[11].

THCa (1,500 mg)

• Evidence: Important chemically, low on direct human therapeutic evidence [12].
• What it is: Acidic precursor to THC. Can represent large share of THC-related content in raw plant material. Decarboxylates to THC during heating and can change during storage/processing [12].
• Psychoactivity: THCa itself does not produce psychoactive effects, but distinction only holds if molecule stays acidic and isn’t decarboxylated [12].
• Research status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, antineoplastic possibilities—not equivalent to established human outcomes [12].
• Bottom line: Highly relevant precursor molecule whose interpretation depends on route, temperature, processing, storage. Any claim must account for possible conversion to THC [12].

Delta-9 THC (90 mg)

• Evidence: Strongest human evidence of psychoactive cannabinoids, but clearest adverse-effect burden [1][13]-[15].
• Institutional support: NCCIH identifies relevance to chemo nausea/vomiting, HIV/AIDS appetite/weight loss, some MS/pain outcomes—many other uses uncertain [1].
• Pain: 2022 systematic review found cannabis products with high THC or comparable THC:CBD ratios may provide short-term pain benefit but increase dizziness, sedation, nausea, discontinuation [13].
• Pharmacokinetics: Inhaled THC: seconds to minutes onset, peaks 15-30 minutes, tapers over few hours. Oral THC: later onset, later peak, longer duration—matters for both benefit and overconsumption risk [14].
• Mental health risk: 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis/schizophrenia outcomes and cannabis use disorder, plus concerning signals for anxiety/depression in nontherapeutic settings [15].
• Broader safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency, withdrawal, pregnancy concerns, accidental pediatric exposure, vape lung injury concerns [1][14][15].
• Bottom line: Legitimate therapeutic relevance in some settings, but carries clearest intoxication, psychiatric, and dose-related safety liabilities [1][13]-[15].

CBN (750 mg)

• Evidence: Weak human evidence; marketing ahead of data [12][16][17].
• Marketing vs. reality: Reputation for sleep/sedation is widespread, but clinical support far thinner than market suggests [16][17].
• Sleep claim review: 2021 narrative review screened 99 human-study abstracts, reviewed 8 full-text articles, found no clinical trials using validated sleep questionnaires or polysomnography to substantiate strong sleep-promoting claims [16].
• Broader sleep literature: 2024 updated review concluded cannabinoid sleep research still doesn’t match real-world use scale; need for better-designed, adequately powered trials remains substantial [17].
• Chemical context: THC can degrade toward CBN under certain conditions, explaining why CBN is often discussed in aging/oxidized cannabis contexts [12].
• Bottom line: Clearest example where cultural reputation is stronger than current clinical evidence base [16][17].

CBC (750 mg)

• Evidence: Emerging, intriguing, overwhelmingly preclinical/review-based [18][19].
• Pharmacology: 2024 focused review argues CBC has distinct PK/PD and receptor behavior vs. better-known cannabinoids. Highlights antinociceptive, antibacterial, anti-seizure as especially interesting research targets [18].
• Older literature: Anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesia, possible neurobiological/antiproliferative relevance—but not strong evidence for patient-facing claims [19].
• Safety caveat: 2024 CBC review notes over-the-counter CBC products already sold despite little evidence establishing clinical efficacy or safety [18].
• Bottom line: Scientifically credible minor cannabinoid deserving more research, not already-validated clinical active [18][19].

The Terpene Story: Why Aroma Matters

Our seven-terpene profile (5% live terpenes) includes limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. Each has evidence profile in GENERAL KNOWLEDGE, but all require conservative interpretation.

Limonene: Multifunctional monoterpene with antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immunomodulatory possibilities in review/preclinical literature [20][21]. However, limonene oxidation products (hydroperoxides) are clinically relevant contact allergens [22].

Myrcene: Often claimed as sedative causing “couch-lock,” but direct human proof is limited. Review literature describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties but explicitly states human studies lacking [20][23].

Caryophyllene: Most mechanistically interesting terpene—selective CB2 receptor agonist, giving it cannabinoid-system relevance [24]. Review literature discusses anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective actions, but human clinical confirmation limited [24].

Pinene: Brain-health framing includes antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but well-designed clinical trials lacking [20][25]. Claims about improving memory or counterbalancing THC cognitive effects remain hypotheses [20][25].

Linalool: Review literature discusses stress, mood, brain-health pharmacology. 2021 brain-health review found enough preclinical signal to justify continued investigation in neurological/psychiatric contexts while emphasizing lack of robust human trials [20][22][25][26]. Oxidized linalool hydroperoxides are recognized allergens [22].

Humulene: 2024 scoping review of 340 articles found broad preclinical evidence for anti-inflammatory effects, some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27]. Valuable for hypothesis generation but not clinically settled [27].

Terpinolene: Least clinically characterized. 2021 systematic review screened 2,449 records, included 57 studies, concluded evidence base dominated by in silico, in vitro, animal studies—human trials sparse [20][28].

Entourage Effect Reality Check: 2024 comprehensive review makes clear that terpene bioactivity is plausible and sometimes compelling, but robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Research Limits and Common Overstatements

Five critical interpretation rules:

1. Evidence base is highly uneven. CBD and delta-9 THC support most detailed statements; others require more caution [1]-[29].
2. Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, and terpene-only data are not interchangeable. Common error is letting evidence from one category stand in for another.
3. Minor cannabinoids and terpenes are commercially interesting because they’re underexplored, but that means claims often become inflated.
4. Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, and route-dependent pharmacokinetics all materially affect real-world interpretation [1][10][11][14].
5. For THCa, chemistry is destiny: storage and heating can change exposure profile by converting acidic cannabinoids to neutral cannabinoids like THC [12].

Overstatements to avoid:

• CBN is clinically proven sleep aid → specific sleep evidence remains weak [16][17]
• Myrcene is proven human sedative → direct human proof limited [20][23]
• Terpenes have proven entourage effects → robust clinical proof limited [20][29]
• THCa is always nonpsychoactive → heating/processing converts to THC [12]
• Delta-8 THC is safe because hemp-derived → psychoactive, less characterized than delta-9 [9]-[11]

Practical Takeaways for Our Formulas

• Most evidence-developed: CBD and delta-9 THC
• Delta-8 THC is not trivial—psychoactive with incomplete safety characterization
• THCa changes with processing—don’t interpret raw vs heated the same way
• CBG, CBN, CBC are scientifically credible but clinically immature vs. CBD/THC
• Terpene claims should be careful and compound-specific

Complete Reference List

[1] National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH.
[2] Talwar A, et al. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy. Exp Neurol. 2023.
[3] Han K, et al. Therapeutic potential of cannabidiol CBD in anxiety disorders. Psychiatry Res. 2024.
[4] Cásedas G, et al. Cannabidiol CBD: A systematic review in pain treatment. Pharmaceuticals. 2024.
[5] Ranum RM, et al. Use of cannabidiol in insomnia management. Cannabis Cannabinoid Res. 2023.
[6] Lo LA, et al. Cannabidiol-associated hepatotoxicity. J Intern Med. 2023.
[7] Nachnani R, et al. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021.
[8] Li S, et al. Cannabigerol CBG: Comprehensive review. Molecules. 2024.
[9] Tagen M, Klumpers LE. Review of delta-8-THC comparative pharmacology. Br J Pharmacol. 2022.
[10] LoParco CR, et al. Delta-8 tetrahydrocannabinol: Scoping review. Addiction. 2023.
[11] Abdel-Kader MS, et al. Chemistry and pharmacology of Delta-8-THC. Molecules. 2024.
[12] Moreno-Sanz G. Critical review of delta9-THCa. Cannabis Cannabinoid Res. 2016.
[13] McDonagh MS, et al. Cannabis-based products for chronic pain. Ann Intern Med. 2022.
[14] Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003.
[15] Rittiphairoj T, et al. High-concentration delta-9-THC products and mental health. Ann Intern Med. 2025.
[16] Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021.
[17] Lavender I, et al. Using cannabis and CBD to sleep: Updated review. Curr Psychiatry Rep. 2024.
[18] Sepulveda DE, et al. Potential of cannabichromene as therapeutic agent. J Pharmacol Exp Ther. 2024.
[19] Zagožen M, et al. Cannabigerol and cannabichromene in Cannabis sativa. Acta Pharm. 2021.
[20] André R, et al. Entourage effect in cannabis medicinal products. Pharmaceuticals. 2024.
[21] Anandakumar P, et al. D-limonene: Multifunctional compound. J Food Biochem. 2021.
[22] Ogueta IA, et al. Limonene and linalool hydroperoxides review. Contact Dermatitis. 2022.
[23] Surendran S, et al. Myrcene: Potential health benefits. Front Nutr. 2021.
[24] Hashiesh HM, et al. CB2 receptor-selective pharmacological properties of beta-caryophyllene. Biomed Pharmacother. 2021.
[25] Weston-Green K, et al. Pinene and linalool as terpene-based medicines for brain health. Front Psychiatry. 2021.
[26] Dos Santos ÉRQ, et al. Linalool as therapeutic tool in depression. Curr Neuropharmacol. 2022.
[27] Dalavaye N, et al. Clinical translation of alpha-humulene: Scoping review. Planta Med. 2024.
[28] Menezes IO, et al. Biological properties of terpinolene: Systematic review. Phytomedicine. 2021.
[29] Russo EB. Taming THC: Potential cannabis synergy. Br J Pharmacol. 2011.

RS1. Simpson R. Phoenix Tears: The Rick Simpson Story. 2012.
RS2. Laurette C. Run From The Cure . 2005.
RS3. Simpson R. Instructions and dosing. phoenixtears.ca.
RS4. Velasco G, et al. Towards use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012.
RS5. Guzmán M, et al. Pilot clinical study of delta-9-THC in recurrent glioblastoma. Br J Cancer. 2006.
RS6. National Cancer Institute. Cannabis and Cannabinoids (PDQ). 2024.

How to Order in Doniphan County

Online: Visit oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/

• Select RSO Sublingual Oil ($129.99) or RSO Vape Cartridge ($49.99)
• Checkout with USPS Priority Mail (2-3 days) or FedEx/UPS Ground (3-5 days)
• Discreet packaging protects your privacy in a small community
• Tracking provided

By Phone: (832) 416-2816

• Speak directly with our team
• Ask questions about dosing, decarboxylation, or which format fits your needs
• We’ll walk you through the process

By Email: [email protected]

• For international orders or custom formulation requests
• We’ll provide documentation for customs if needed

Payment: We accept major credit cards, cryptocurrency for international orders, and can discuss other arrangements for Doniphan County customers who need flexibility.

The Doniphan County Connection: Why This Matters Locally

Doniphan County is rural. The nearest major medical centers are in St. Joseph (30 minutes) or Kansas City (2+ hours). For cancer patients at Northeast Kansas Cancer Center, chronic pain sufferers trying to avoid opioids, veterans at the VA clinic in St. Joseph dealing with PTSD—access to specialized cannabis products is limited. Missouri’s recreational dispensaries are an option, but they require travel, have limited product selection, and don’t publish open-source formulas.

Our open-source approach means that even if you can’t afford $129.99 right now, you can see exactly what’s in the bottle and work with a local compounding pharmacy or source distillates yourself. That’s accessibility that respects Doniphan County’s independent spirit.

The patient-controlled potency feature is crucial for Doniphan County’s working families. You can use the raw formula during the day while operating equipment, driving to town, or caring for livestock without any impairment. Then decarb a portion at night for full-strength relief when you’re off the clock. That flexibility doesn’t exist in traditional RSO or most dispensary products.

Our third-party testing matters because Doniphan County residents deserve to know what they’re putting in their bodies. When you buy from an unverified source—or make it yourself using solvents—you’re taking risks with residual chemicals that our solvent-free production eliminates.

The Bentley story resonates in a community where dogs aren’t just pets—they’re family, they’re working partners on farms, they’re companions for isolated seniors. That story proves our formulas weren’t created in a lab by people chasing profits. They were forged through love, desperation, and ten years of real-world testing.

The ABC13 media record matters because it’s independent verification. We didn’t pay for those features. Houston’s number-one news source kept coming back because we tell the truth, even when it’s uncomfortable—like admitting we don’t know everything, or that delta-8 carries risks, or that our founder has a cannabis conviction. That honesty is the same honesty we bring to this guide for Doniphan County.

Final Thoughts for Doniphan County

Rick Simpson’s legacy is complicated. He was not a medical authority, but he was a catalyst. He gave his oil away for free when no one else would. He taught people to make it themselves. He operated illegally because the law left him no choice. Today, we operate legally under the Farm Bill because the law finally allows it—but we maintain his ethos of accessibility, transparency, and patient control.

OilWell RSO is not traditional RSO. It’s a modern, formulated, multi-cannabinoid product that solves the problems Simpson’s approach created: standardization, safety, precision, terpene inclusion, patient-controlled potency, and evidence-informed education.

For Doniphan County residents dealing with cancer, chronic pain, PTSD, insomnia, or any condition where conventional medicine has fallen short, we offer a legal, tested, transparent option. You can buy it, you can make it yourself using our published formula, or you can call us and talk through whether it’s right for you.

We’re not here to sell snake oil. We’re not here to sell hope. We’re here to provide the best possible version of information and product so you can give it a fair shot and decide for yourself whether it’s right or wrong for you.

That’s the promise we made in 2019 on ABC13, and it’s the promise we keep today for every customer in Doniphan County.

Contact us:

• Phone: (832) 416-2816
• Email: [email protected]
• Website: oilwellcbd.com
• Instagram: @oilwellcbd
• Address: 810 Richmond Ave, Houston, TX 77006

Order RSO for delivery to Doniphan County: oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/

We’re here when you’re ready. And if you’re not ready, we’re still here—with the education, the transparency, and the open-source formulas that prove we’re in this for the right reasons.